C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/48 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01) C07K 16/10 (2006.01) C12N 7/01 (2006.01) C12N 7/04 (2006.01)
Patent
CA 2339850
A novel HIV vaccine is provided. In particular, the vaccine comprises an avirulent and non-cytolytic recombinant HIV wherein the NSS of the virus' envelope glycoprotein is replaced with a non-cytolytic signal sequence and nef gene of the virus is deleted which renders the virus avirulent.
Ce nouveau vaccin contre le virus de l'immunodéficience humaine (VIH) renferme, notamment, un VIH de recombinaison dépourvu de virulence et non cytolytique, la séquence-signal naturelle (NSS) de la glycoprotéine d'enveloppe du virus ayant été remplacée par une séquence-signal non cytolytique et le gène nef du virus ayant été délété, ce qui supprime sa virulence.
Kang Chil-Yong
Li Yan
Krupnik Eduardo
University Of Western Ontario
LandOfFree
A non-cytolytic recombinant hiv-1 vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A non-cytolytic recombinant hiv-1 vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A non-cytolytic recombinant hiv-1 vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1819671